AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate ...
16h
Hosted on MSNStudy Finds Exenatide Not Beneficial for Parkinson DiseaseThe glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity, ...
22hon MSN
Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...
It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...
Ken Hall takes a look at two big-name retirement shares in the FTSE 100 with market-leading positions and track records of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results